{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":487,"total_is_capped":false,"direct_labels_cover":4,"predictions_cover":487,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"eac09bd1f6b0","filters":{"venue":"Multiple Sclerosis and Related Disorders"}},"results":[{"id":"W2463810424","doi":"10.1016/j.msard.2016.07.003","title":"Brain health: time matters in multiple sclerosis","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":451,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Actelion Pharmaceuticals; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Università degli Studi di Firenze; Karolinska Institutet; Multiple Sclerosis Society; Multiple Sclerosis Trust; Universität Basel; Univerzita Karlova v Praze; Sanofi Genzyme; F. Hoffmann-La Roche; Sanofi; AbbVie; Biogen; Royal Holloway, University of London; Novartis","keywords":"Medicine; Multiple sclerosis; Disease; Cognition; Action (physics); Health care; Intensive care medicine; Psychiatry; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.08942027039325148,"gpt":0.320134813110155,"spread":0.2307145427169035,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001491824,0.001522448,0.004939076,0.001516243,0.0006064049,0.0001342215,0.0005271223,0.001175104,0.0005728066],"category_scores_gemma":[0.001785244,0.001087438,0.001275018,0.001470902,0.0009431464,0.0002697713,0.0006429857,0.001699606,0.001062105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008129958,"about_ca_system_score_gemma":0.0005009532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008660677,"about_ca_topic_score_gemma":0.0004391669,"domain_scores_codex":[0.9914975,0.000945189,0.002474287,0.002047205,0.00100401,0.00203181],"domain_scores_gemma":[0.9942346,0.002646356,0.0008525678,0.001200672,0.0001207561,0.0009450345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001125544,0.0004972977,0.001388135,0.008158703,0.0008097467,0.000009158035,0.000392543,0.000002559871,0.0001021251,0.00000474908,0.02127697,0.9672455],"study_design_scores_gemma":[0.01021684,0.0003965323,0.01049837,0.09503075,0.0003085793,0.00003426919,0.0001603613,0.0003347499,0.000002395649,0.00001863027,0.8816637,0.001334855],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004198444,0.9788709,0.00001225417,0.01393239,0.0003774955,0.005084198,0.000475666,0.0003185731,0.0005086586],"genre_scores_gemma":[0.001186327,0.9940313,0.0002764973,0.0009489927,0.0001179342,0.0008107718,0.0004270531,0.0003629791,0.001838216],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9659106,"threshold_uncertainty_score":0.9997524,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150598981","doi":"10.1016/j.msard.2012.06.002","title":"Treatment of neuromyelitis optica: Review and recommendations","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Neuromyelitis optica; Medicine; Azathioprine; Rituximab; Multiple sclerosis; Mitoxantrone; Natalizumab; Prednisone; Optic neuritis; Methotrexate; Disease; Demyelinating disease; Immunology; Intensive care medicine; Dermatology; Internal medicine; Lymphoma; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.05910238043995268,"gpt":0.3050308255822414,"spread":0.2459284451422887,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001428965,0.0001973261,0.0004990194,0.00008037558,0.0001651214,0.00000938811,0.00003371458,0.00008014945,0.0001457873],"category_scores_gemma":[0.0002645431,0.0001400606,0.000132117,0.0002224665,0.0002624364,0.0001211229,0.00006233574,0.0001088563,0.000008196207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003278852,"about_ca_system_score_gemma":0.00001518273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001441806,"about_ca_topic_score_gemma":0.00001638645,"domain_scores_codex":[0.9988211,0.00007025008,0.0003629506,0.0002452502,0.0001557365,0.0003446548],"domain_scores_gemma":[0.999122,0.0002322689,0.0000891758,0.0002302827,0.00006456468,0.0002617033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001080994,0.001887698,0.3232812,0.001805506,0.001191125,9.721487e-7,0.003019867,0.000002397074,0.008431775,0.0002129176,0.003356433,0.656702],"study_design_scores_gemma":[0.005691293,0.0007601629,0.9560716,0.001183613,0.0007065177,0.00002281492,0.0006892966,0.0004664244,0.0003211792,0.000014879,0.03381795,0.0002542841],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6125699,0.3434561,0.00002906082,0.03561269,0.0002658485,0.002802478,0.0001296348,0.0001285897,0.005005687],"genre_scores_gemma":[0.5768473,0.4221902,0.0006078083,0.00007998644,0.00001406543,0.00006043471,0.00002637882,0.00001419889,0.0001596505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6564478,"threshold_uncertainty_score":0.5711504,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2134894009","doi":"10.1016/j.msard.2015.10.004","title":"Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; University of Calgary; George & Fay Yee Centre for Healthcare Innovation; University of Manitoba","funders":"Canadian Institutes of Health Research; Dalhousie University; Multiple Sclerosis Society of Canada; Research Manitoba","keywords":"Medicine; Anxiety; Meta-analysis; Depression (economics); PsycINFO; CINAHL; MEDLINE; Population; Psychological intervention; Randomized controlled trial; Clinical trial; Psychiatry; Clinical psychology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1842183961771095,"gpt":0.3661625790416798,"spread":0.1819441828645703,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001762748,0.0008508677,0.01072154,0.001152697,0.0002381496,0.00006110666,0.0002003543,0.0004721452,0.0000389542],"category_scores_gemma":[0.00183016,0.0005068624,0.0026264,0.001739811,0.0005272219,0.0001613189,0.0003060605,0.0005943815,0.000001215955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000101749,"about_ca_system_score_gemma":0.00009611301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003647253,"about_ca_topic_score_gemma":0.001193619,"domain_scores_codex":[0.9951055,0.0005950252,0.00202418,0.001170877,0.0005584669,0.0005459583],"domain_scores_gemma":[0.9962374,0.001256195,0.001058609,0.0007507771,0.0003105792,0.0003864394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00006400234,0.0004003975,0.001549908,0.8299914,0.1414698,8.432021e-7,0.0004554198,0.000008562851,0.000005086092,0.000003179628,0.0001779314,0.0258735],"study_design_scores_gemma":[0.00315251,0.0002706848,0.002639684,0.2356884,0.7543109,0.000008831727,0.0005280096,0.0008947652,6.283569e-7,0.000002547825,0.001948239,0.0005547351],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002484363,0.9885854,0.00004769651,0.0002334423,0.00002085924,0.009878826,0.0009010345,0.00004434633,0.00004003352],"genre_scores_gemma":[0.007844049,0.9874913,0.0006867195,0.00003710668,0.000005019841,0.00332341,0.0003317222,0.00009706539,0.0001836131],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6128411,"threshold_uncertainty_score":0.9997383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2625299651","doi":"10.1016/j.msard.2017.06.003","title":"The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Expanded Disability Status Scale; Medicine; Multiple sclerosis; Physical therapy; Physical medicine and rehabilitation; Physical disability; MEDLINE; Inclusion (mineral); Psychology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.08286083481255867,"gpt":0.3428479991164018,"spread":0.2599871643038431,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.005358353,0.001071893,0.006206577,0.0003607616,0.001645419,0.0001672407,0.0005444805,0.0006285322,0.00001306065],"category_scores_gemma":[0.004491387,0.0005138041,0.0005652126,0.001408162,0.003365542,0.0002299712,0.0004202187,0.002271042,0.000004273367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002912183,"about_ca_system_score_gemma":0.0002852542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009097827,"about_ca_topic_score_gemma":0.003617337,"domain_scores_codex":[0.99209,0.002242236,0.001752398,0.001527548,0.001253804,0.001134043],"domain_scores_gemma":[0.9904892,0.00574247,0.0008993088,0.002061165,0.0003735887,0.0004342827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004930712,0.0001848226,0.004785213,0.5495877,0.0008521955,0.000003085506,0.0009059011,6.808823e-7,5.69306e-7,0.000001251969,0.00002453898,0.4431609],"study_design_scores_gemma":[0.006809576,0.001505029,0.01499558,0.9592826,0.005217182,0.00005407338,0.002509259,0.00009968204,9.360928e-7,0.000002837447,0.00884362,0.0006796391],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003187557,0.9748787,3.157685e-7,0.0005269682,0.00008329503,0.02089213,0.0001517863,0.00007527698,0.000203923],"genre_scores_gemma":[0.03605452,0.9572798,0.0000473831,0.00000433664,0.00003674709,0.006261355,0.00007183918,0.0001404309,0.0001035879],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4424813,"threshold_uncertainty_score":0.9997314,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2771966364","doi":"10.1016/j.msard.2017.12.007","title":"The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Nova Scotia Health Authority; Dalhousie University; University of Manitoba","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Heart and Stroke Foundation of Canada","keywords":"Multiple sclerosis; Medicine; Anxiety; Depression (economics); Reliability (semiconductor); Clinical psychology; Psychiatry; Validity; Psychometrics","retraction":null,"screen_n_in":null,"score":{"opus":0.0754390113063081,"gpt":0.2944983733866809,"spread":0.2190593620803728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001768885,0.0003762461,0.0006657855,0.000137984,0.002246203,0.0001623203,0.0002531539,0.000299048,0.000004217449],"category_scores_gemma":[0.007111622,0.0002582076,0.0001881965,0.0001506429,0.001849801,0.0003169021,0.0005103072,0.0004712673,4.098599e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003918045,"about_ca_system_score_gemma":0.00003667643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002186217,"about_ca_topic_score_gemma":0.004767989,"domain_scores_codex":[0.9971849,0.0002021099,0.0006690279,0.0008318979,0.0004730731,0.0006389563],"domain_scores_gemma":[0.9968573,0.001542069,0.0003484082,0.0008043696,0.0001856888,0.000262114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007242715,0.0001664029,0.7633522,0.0001730027,0.00007344205,1.063669e-7,0.0005760705,0.00005597888,0.006696534,0.000006012893,0.00008503265,0.2280909],"study_design_scores_gemma":[0.009947157,0.0002161125,0.9660196,0.0006542307,0.0000923355,0.000001223069,0.001033461,0.01930234,0.000921194,0.0002559584,0.00127843,0.0002779361],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907243,0.003702556,0.0002858319,0.002688927,0.0001303625,0.002130258,0.00006973853,0.00004878184,0.0002192904],"genre_scores_gemma":[0.9083691,0.09000667,0.001261769,0.00001770421,0.00002132682,0.0002271033,0.00001320824,0.00004348542,0.00003966812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.227813,"threshold_uncertainty_score":0.999987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2468098431","doi":"10.1016/j.msard.2016.07.001","title":"Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Randomized controlled trial; Multiple sclerosis; Quality of life (healthcare); Internal medicine; Body mass index; Physical therapy; Expanded Disability Status Scale; Psychological intervention; Hyperlipidemia; Disease; Diabetes mellitus; Endocrinology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.03704473252661662,"gpt":0.2556401940503584,"spread":0.2185954615237418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002218279,0.0008169835,0.003486542,0.0008065637,0.0004341765,0.00008768609,0.0002865258,0.0005722023,0.0003035176],"category_scores_gemma":[0.00767614,0.0004746299,0.001150162,0.0006730466,0.001624092,0.0002618288,0.0001985447,0.0006397514,0.00007955233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002275196,"about_ca_system_score_gemma":0.0001734646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006566159,"about_ca_topic_score_gemma":0.001055893,"domain_scores_codex":[0.9934749,0.001017831,0.001954822,0.001219194,0.001022057,0.00131117],"domain_scores_gemma":[0.9920952,0.005941684,0.00048597,0.0007176338,0.0001996232,0.0005598487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9459551,0.001795764,0.009938458,0.0001256891,0.0009543903,0.00001054411,0.000454635,0.0001121165,0.01807896,0.00003345102,0.0006032985,0.02193757],"study_design_scores_gemma":[0.9516163,0.0009800678,0.02562209,0.002574511,0.0003131981,0.000001537692,0.00040692,0.01643678,0.001125956,0.00007511611,0.0002190435,0.0006284932],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.974536,0.003073111,0.0005673635,0.005523134,0.0007209496,0.0140874,0.000152473,0.0003471295,0.0009924658],"genre_scores_gemma":[0.9794608,0.01588169,0.0002717147,0.0002375303,0.00010891,0.003479605,0.00006603358,0.0001147569,0.0003789794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02130907,"threshold_uncertainty_score":0.9997705,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2737064420","doi":"10.1016/j.msard.2017.07.020","title":"Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Meta-analysis; Multiple sclerosis; Cochrane Library; Internal medicine; MEDLINE; Relative risk; Causality (physics); Clinically isolated syndrome; CINAHL; Physical therapy; Psychiatry; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.344363908382509,"gpt":0.4033033450547217,"spread":0.05893943667221269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003496908,0.001189868,0.009699583,0.0006275158,0.001893759,0.0004948702,0.0003952747,0.0006657183,0.00004830516],"category_scores_gemma":[0.005250074,0.000673481,0.002810882,0.0007432076,0.0007828514,0.000308974,0.000509752,0.0008363677,0.000002245246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001448874,"about_ca_system_score_gemma":0.0001080213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005621896,"about_ca_topic_score_gemma":0.0003261224,"domain_scores_codex":[0.9937423,0.001111376,0.00219659,0.001455977,0.0006731785,0.0008205356],"domain_scores_gemma":[0.9936194,0.002394613,0.001795972,0.001479632,0.000328236,0.0003821209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00003352543,0.000135583,0.00021297,0.7481399,0.2117457,0.000001693883,0.00059976,0.000005918056,0.00001548373,0.00001080388,0.0002213309,0.03887741],"study_design_scores_gemma":[0.002016869,0.000115421,0.0006340639,0.09799277,0.8828756,0.00003195368,0.0003224034,0.005567731,7.944791e-7,0.00001369087,0.009589615,0.0008390639],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001195725,0.9849604,0.0001320605,0.0009478852,0.00009980048,0.01308965,0.0005380932,0.00008188815,0.0000306456],"genre_scores_gemma":[0.01018595,0.986591,0.0004277937,0.0002053695,0.00004030246,0.001939669,0.0002468624,0.0001544868,0.000208586],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6711299,"threshold_uncertainty_score":0.9995716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2978655339","doi":"10.1016/j.msard.2019.101427","title":"The multiple sclerosis gut microbiota: A systematic review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; University of Toronto; University of Manitoba; Public Health Agency of Canada; University of British Columbia","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Multiple sclerosis; Medicine; Gut flora; Neuroscience; Immunology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04001760140771747,"gpt":0.2651932013909192,"spread":0.2251755999832017,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007952266,0.000892763,0.002451376,0.0001042135,0.000707373,0.0001514708,0.0007131702,0.001023849,0.0000178595],"category_scores_gemma":[0.0004935784,0.0005577789,0.001156248,0.000383886,0.0002847483,0.000008852093,0.0003923894,0.0006501808,0.0002178799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006543617,"about_ca_system_score_gemma":0.0002464663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007513166,"about_ca_topic_score_gemma":0.0001846536,"domain_scores_codex":[0.995693,0.0006276806,0.001570358,0.001103249,0.0002034871,0.0008022332],"domain_scores_gemma":[0.9970776,0.0002897456,0.0009573331,0.001365765,0.0001002166,0.0002093707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002033263,0.0001548676,0.00002743526,0.8878259,0.001331865,7.514537e-7,0.00005110987,0.000001721328,0.002649216,0.0000129392,0.01131983,0.096604],"study_design_scores_gemma":[0.0009436694,0.000122789,0.00007353885,0.3628979,0.002468103,0.00003198725,0.00005567062,0.00001185683,0.000005991615,0.000002363407,0.6325855,0.0008006291],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008933881,0.9934259,0.000006641409,0.0002147816,0.0006227722,0.005240624,0.0001996181,0.00004288787,0.0001574184],"genre_scores_gemma":[0.0005872309,0.9959742,0.00004282729,0.0003178116,0.00005576869,0.0004222845,0.0007447986,0.0001599636,0.001695124],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6212657,"threshold_uncertainty_score":0.9996874,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2770280018","doi":"10.1016/j.msard.2017.11.013","title":"Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Deutsche Stiftung Neurologie; Biogen Idec; Merck KGaA; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Novartis; Bayer","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Physical therapy; Physical medicine and rehabilitation; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.05478649989018387,"gpt":0.2678190299087292,"spread":0.2130325300185454,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006259103,0.0004077188,0.0006508866,0.000234668,0.0008553528,0.0001488303,0.0003520928,0.0001747384,0.00002229841],"category_scores_gemma":[0.001162799,0.0002391787,0.0001667815,0.0003336944,0.0008012803,0.0002006219,0.0004036415,0.0005757895,0.000002759742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002501399,"about_ca_system_score_gemma":0.00004086268,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04739796,"about_ca_topic_score_gemma":0.007528378,"domain_scores_codex":[0.9973871,0.0004389974,0.0006138345,0.0005870292,0.0004163319,0.0005567049],"domain_scores_gemma":[0.9975247,0.00112044,0.0002967581,0.000844297,0.00008351616,0.0001303326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001243883,0.001617195,0.7330263,0.00007622248,0.0009125168,0.000006185659,0.1381579,0.0002721683,0.02053555,0.0002987391,0.0001190052,0.1037344],"study_design_scores_gemma":[0.01423699,0.0007538055,0.847315,0.0007903794,0.0001081262,8.679145e-7,0.1322242,0.003364946,0.0001489963,0.00006636204,0.0007552374,0.0002351385],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828804,0.009332773,0.000001801501,0.004185023,0.000159978,0.002386302,0.00009884019,0.00003005244,0.0009249027],"genre_scores_gemma":[0.9394783,0.05993678,0.00009133347,0.00007436741,0.00003521431,0.0003035668,0.00003192369,0.00003766528,0.00001089953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1142887,"threshold_uncertainty_score":0.9753426,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007702618","doi":"10.1016/j.msard.2014.08.002","title":"Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; London Health Sciences Centre","funders":"Celgene","keywords":"Multiple sclerosis; Medicine; Randomized controlled trial; Placebo; Placenta; Human placenta; Internal medicine; Pregnancy; Immunology; Pathology; Alternative medicine; Fetus","retraction":null,"screen_n_in":null,"score":{"opus":0.02878630039651637,"gpt":0.2540695841590502,"spread":0.2252832837625338,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001557885,0.0007474507,0.002224034,0.0002859652,0.0008402935,0.00009218256,0.0002969387,0.0003080575,0.000123504],"category_scores_gemma":[0.0008373514,0.0004049745,0.0006743746,0.0003827405,0.0007974874,0.0001143667,0.00008671425,0.0003597081,0.00001884417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001290263,"about_ca_system_score_gemma":0.00007405687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003069415,"about_ca_topic_score_gemma":0.003078219,"domain_scores_codex":[0.9951856,0.0007614527,0.001282771,0.001032029,0.0008333767,0.000904754],"domain_scores_gemma":[0.9923413,0.005444115,0.0005617156,0.0009176184,0.0003083303,0.0004269054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8202553,0.01495766,0.05385875,0.000457839,0.006019803,0.000006727212,0.01374172,0.002340856,0.04726107,0.00002302158,0.0002975278,0.04077972],"study_design_scores_gemma":[0.8636104,0.006780205,0.02537199,0.0005737958,0.001620602,0.000003533146,0.007479314,0.09072582,0.002944584,0.000009200333,0.0003967341,0.0004838043],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9725447,0.002524287,0.0002693049,0.0004272658,0.0002186826,0.02351225,0.00005896663,0.0001239286,0.0003206306],"genre_scores_gemma":[0.9910708,0.003329944,0.0003946888,0.00004310878,0.00007127626,0.003997152,0.00007968171,0.0001354394,0.0008778953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08838496,"threshold_uncertainty_score":0.9998402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143842592","doi":"10.1016/j.msard.2015.06.011","title":"Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Medical Research Council; McGill University","keywords":"Telerehabilitation; Psychological intervention; Medicine; Observational study; Physical therapy; Quality of life (healthcare); Physical medicine and rehabilitation; Intervention (counseling); MEDLINE; Randomized controlled trial; Telemedicine; Systematic review; Evidence-based medicine; Health care; Alternative medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.09180659834877229,"gpt":0.3407987065212382,"spread":0.2489921081724659,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003335836,0.0009225162,0.006462634,0.0009355848,0.0001707603,0.00004181392,0.0003152419,0.0005426386,0.00002729256],"category_scores_gemma":[0.005216004,0.0006150565,0.001391342,0.001880155,0.0006609527,0.0002045703,0.0002361397,0.00102905,0.00002341244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004590105,"about_ca_system_score_gemma":0.000349791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003931793,"about_ca_topic_score_gemma":0.0003534385,"domain_scores_codex":[0.9928344,0.002159531,0.002350214,0.001086302,0.0009025772,0.000666988],"domain_scores_gemma":[0.9944733,0.002738756,0.001049894,0.0009311523,0.000454444,0.000352485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001383649,0.0008604354,0.001177143,0.9249263,0.001490324,0.000003063996,0.000411743,0.000008785236,0.00001643136,0.000005726187,0.00007938823,0.07088228],"study_design_scores_gemma":[0.005488874,0.000788421,0.0105508,0.9750605,0.005582591,0.00001879603,0.0007249484,0.0001316079,0.000001474813,0.000006746796,0.001058241,0.0005869881],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001198948,0.9833682,0.00002274865,0.0000794945,0.0001004831,0.01478785,0.0001936207,0.00009551159,0.0001531498],"genre_scores_gemma":[0.03012397,0.9651992,0.0002633723,0.00000897367,0.000009980711,0.003964445,0.0002266494,0.0001453407,0.00005805418],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.07029529,"threshold_uncertainty_score":0.9996301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2900596677","doi":"10.1016/j.msard.2018.11.021","title":"Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Tolerability; Adverse effect; Placebo; Internal medicine; Multiple sclerosis; Clinical trial; Cohort; Gastroenterology; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03259422897934258,"gpt":0.2599261944930275,"spread":0.2273319655136849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004415631,0.0004184604,0.001049212,0.0006388868,0.0002574034,0.00002570364,0.000222935,0.0002113079,0.0001225301],"category_scores_gemma":[0.0003058867,0.0002339404,0.0002588877,0.002546338,0.001098353,0.000181307,0.00005482274,0.0002378944,0.000003448075],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001147841,"about_ca_system_score_gemma":0.00006561981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003299218,"about_ca_topic_score_gemma":0.008622074,"domain_scores_codex":[0.9968971,0.0003138887,0.0009048277,0.0006395373,0.000698765,0.0005458564],"domain_scores_gemma":[0.9978114,0.0004167396,0.0003330731,0.0007489934,0.0005047213,0.0001850822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002991837,0.004634396,0.9394008,0.00005147583,0.00189971,8.452737e-7,0.005943624,0.0003520099,0.002970007,0.00000671865,0.00003671619,0.04171185],"study_design_scores_gemma":[0.01733963,0.004272646,0.9637292,0.0003025538,0.0008350618,3.093892e-7,0.002957519,0.00891526,0.0008785634,0.000004480071,0.0005261549,0.0002386263],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966251,0.000757058,0.00009724819,0.0003028336,0.00005209335,0.001634901,0.0002492691,0.00003956029,0.0002419318],"genre_scores_gemma":[0.9921265,0.006562028,0.0006829029,0.00003729862,0.00001929126,0.0001039013,0.0003934865,0.00003931079,0.00003529151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04147322,"threshold_uncertainty_score":0.9539814,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122096478","doi":"10.1016/j.msard.2015.10.005","title":"Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; University of British Columbia; Hotchkiss Brain Institute; University of Calgary","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Cholesterol; Multiple sclerosis; Medicine; Apolipoprotein B; Pathogenesis; Myelin; Internal medicine; Apolipoprotein E; Cerebrospinal fluid; Disease; Lipoprotein; Endocrinology; Central nervous system; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1050603024165684,"gpt":0.3128429129926238,"spread":0.2077826105760554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009613266,0.001199853,0.003510335,0.00107806,0.0002689098,0.0001087853,0.0003081746,0.0007565449,0.0000244697],"category_scores_gemma":[0.001492578,0.0008364,0.000532534,0.001108159,0.001207968,0.0003708037,0.0003350078,0.001506103,0.0000169565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002563303,"about_ca_system_score_gemma":0.0003337743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005551359,"about_ca_topic_score_gemma":0.001009603,"domain_scores_codex":[0.9943171,0.0005367097,0.001731615,0.001412885,0.001070436,0.0009312196],"domain_scores_gemma":[0.9958022,0.001267293,0.0007668548,0.0009863152,0.0002322412,0.0009451265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006172702,0.0006967026,0.6020883,0.01086502,0.00105249,0.000006517953,0.0007035557,0.00003326963,0.000007251793,0.000006275562,0.0001761399,0.3837472],"study_design_scores_gemma":[0.01446221,0.0004206164,0.9165679,0.03810984,0.001612432,0.00001109844,0.0004663456,0.0003824015,7.931773e-7,0.0000124866,0.02707054,0.0008833328],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1138198,0.8802319,0.000006070111,0.0003399841,0.0001477779,0.004755389,0.0003365171,0.0001172599,0.0002453294],"genre_scores_gemma":[0.2981982,0.7005587,0.0001510024,0.00003455172,0.00002036002,0.0004843067,0.0001945684,0.0001580633,0.0002003221],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3828639,"threshold_uncertainty_score":0.9994087,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971770137","doi":"10.1016/j.msard.2015.02.005","title":"Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":107,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Centre Hospitalier de l’Université de Montréal","funders":"EMD Serono; Multiple Sclerosis Society; Teva Pharmaceutical Industries; Sanofi","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Physical medicine and rehabilitation; Neuroscience; Psychiatry; Psychology; Artificial intelligence","retraction":null,"screen_n_in":null,"score":{"opus":0.2841576429537343,"gpt":0.3570499051392593,"spread":0.07289226218552503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002649944,0.001260802,0.002217689,0.000571446,0.002816953,0.0001558062,0.001948984,0.001368314,0.00006750604],"category_scores_gemma":[0.003176695,0.0008311378,0.0006113097,0.001887124,0.0004398685,0.0004241838,0.001726781,0.006436046,0.0001051027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00205955,"about_ca_system_score_gemma":0.0005386194,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03331306,"about_ca_topic_score_gemma":0.02708423,"domain_scores_codex":[0.9811895,0.01118777,0.003276348,0.001659502,0.001069237,0.001617677],"domain_scores_gemma":[0.9850599,0.01004305,0.001798049,0.002447098,0.0003018754,0.0003499959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"qualitative","study_design_scores_codex":[0.0001704295,0.001117956,0.05063687,0.003121485,0.0004483141,0.000002924156,0.2000856,0.0002112042,0.00001271126,0.0002877671,0.0006360602,0.7432687],"study_design_scores_gemma":[0.008194093,0.0002467559,0.0794413,0.07150988,0.0005327163,0.000001330285,0.4792492,0.001356233,2.304715e-7,0.0001224709,0.3577853,0.001560502],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01614589,0.967945,0.000004684438,0.001466255,0.00149556,0.01141635,0.0006738389,0.0001977482,0.0006546443],"genre_scores_gemma":[0.3338761,0.6606828,0.0002036035,0.0003644171,0.00008070176,0.004155063,0.000468523,0.000161375,0.000007456237],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7417082,"threshold_uncertainty_score":0.9999281,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2894796500","doi":"10.1016/j.msard.2018.09.036","title":"Use of eHealth and mHealth technology by persons with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Canon Foundation for Scientific Research; National Multiple Sclerosis Society; Research Manitoba; Biogen; Canadian Institutes of Health Research; Novartis","keywords":"eHealth; mHealth; Telehealth; Telemedicine; Health Information National Trends Survey; Medicine; The Internet; Health informatics; Health care; Health information technology; Patient portal; Descriptive statistics; Internet privacy; Family medicine; Medical education; Nursing; World Wide Web; Health information; Computer science; Public health; Psychological intervention","retraction":null,"screen_n_in":null,"score":{"opus":0.05599073180113199,"gpt":0.2815563722829021,"spread":0.2255656404817701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0003548296,0.0004568398,0.0008644213,0.0005318563,0.0007028813,0.00005148229,0.000145854,0.0004120772,0.0000600858],"category_scores_gemma":[0.0008220401,0.0003452603,0.000103677,0.001032355,0.002789179,0.00024549,0.0002315262,0.0005951489,0.00001021421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008366739,"about_ca_system_score_gemma":0.0001192543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002064507,"about_ca_topic_score_gemma":0.001310903,"domain_scores_codex":[0.9969031,0.0001263124,0.0006431799,0.0008981609,0.0005270298,0.0009021937],"domain_scores_gemma":[0.9978765,0.000459782,0.0002849577,0.0005662607,0.000312398,0.0005000937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001217715,0.0007836177,0.8206971,0.0003876429,0.0006123387,0.000001862439,0.002132719,0.000008428518,0.07362209,0.00005002133,0.004856974,0.09562943],"study_design_scores_gemma":[0.0138023,0.003696231,0.9576499,0.001465793,0.0002724351,0.00002438145,0.003584635,0.007041215,0.00540186,0.00003119705,0.006395331,0.0006347133],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881715,0.003970756,0.000121102,0.005673705,0.00009105141,0.001329971,0.000189438,0.000200461,0.0002519751],"genre_scores_gemma":[0.9726562,0.02371493,0.00293019,0.0001976708,0.000030234,0.00009459855,0.0000441744,0.00008242438,0.0002495825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1369528,"threshold_uncertainty_score":0.9999247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2526902842","doi":"10.1016/j.msard.2016.09.005","title":"Language disorders in multiple sclerosis: A systematic review","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Université Laval","funders":"","keywords":"PsycINFO; Multiple sclerosis; Medicine; Cognition; MEDLINE; English language; Psychology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.06242412058653238,"gpt":0.3117931399391681,"spread":0.2493690193526358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001666495,0.00170692,0.007796494,0.001153475,0.0004230594,0.0001120755,0.00068655,0.001098731,0.0002461312],"category_scores_gemma":[0.005783245,0.001097909,0.001848514,0.001776668,0.0007404361,0.000282016,0.0006255842,0.001675034,0.0004528071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005000318,"about_ca_system_score_gemma":0.0002841315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004546083,"about_ca_topic_score_gemma":0.001214592,"domain_scores_codex":[0.9908428,0.001188023,0.00321149,0.001930824,0.001181724,0.001645112],"domain_scores_gemma":[0.9941931,0.002178665,0.001102824,0.00171735,0.0001402767,0.0006677695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000361065,0.0004164199,0.0003331606,0.5920595,0.001073552,0.000008493028,0.0003480955,4.801613e-7,0.00001689193,0.000005682273,0.0005685425,0.4051331],"study_design_scores_gemma":[0.00559741,0.0001929012,0.001287969,0.9409272,0.003093257,0.00002470806,0.0004385956,0.0001064646,0.000001043527,0.00001113116,0.04702778,0.001291541],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000119883,0.9833585,0.000009377593,0.0007738105,0.0003150955,0.01380766,0.0002735544,0.0003122682,0.001029834],"genre_scores_gemma":[0.00415048,0.9901021,0.00009692583,0.0001634699,0.00006757362,0.004000038,0.0002733178,0.0003429133,0.0008031568],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4038415,"threshold_uncertainty_score":0.9995677,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2912026765","doi":"10.1016/j.msard.2019.01.044","title":"Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Schweizerische Multiple Sklerose Gesellschaft; European Commission; Universitätsspital Basel; Bayer HealthCare; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Novartis Foundation; F. Hoffmann-La Roche","keywords":"Medicine; Ocrelizumab; Oratorio; Multiple sclerosis; Opera; Internal medicine; Literature; Psychiatry; Musical; Art","retraction":null,"screen_n_in":null,"score":{"opus":0.0340385116582444,"gpt":0.2778177616240176,"spread":0.2437792499657732,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008733651,0.0006203403,0.001446265,0.0002121914,0.0009667028,0.0001640495,0.000192858,0.0002648857,0.00002671047],"category_scores_gemma":[0.002909814,0.0003560045,0.000114239,0.0005821034,0.001604808,0.0005408705,0.000766361,0.0007491551,0.000004505277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001383471,"about_ca_system_score_gemma":0.00008484554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008448737,"about_ca_topic_score_gemma":0.0002102567,"domain_scores_codex":[0.9957859,0.0004517104,0.001032659,0.001242643,0.0007896337,0.0006974453],"domain_scores_gemma":[0.9964347,0.001977239,0.0003538275,0.0006083291,0.000348772,0.0002771096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1492018,0.001768986,0.7132612,0.0002043697,0.001345878,0.000009248649,0.06500603,0.0001045593,0.008751341,0.000008824056,0.0003515187,0.05998621],"study_design_scores_gemma":[0.415179,0.00102871,0.5661527,0.003790585,0.0001610366,0.000001776713,0.008621794,0.004167132,0.0001809646,0.00001268618,0.0002162362,0.000487347],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9705535,0.02233043,0.000003314379,0.001510614,0.0002082697,0.005060262,0.0001193773,0.00008645965,0.0001277685],"genre_scores_gemma":[0.9599916,0.03845803,0.0005988757,0.0002335873,0.00002958627,0.0003979866,0.0001556276,0.0000656798,0.00006902521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2659773,"threshold_uncertainty_score":0.9998892,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3033837102","doi":"10.1016/j.msard.2020.102260","title":"Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epidemiology; MEDLINE; Meta-analysis; Systematic review; Incidence (geometry); Disease; Data extraction; Multiple sclerosis; Pediatrics; Pathology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1753109828645792,"gpt":0.3520285623759122,"spread":0.176717579511333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002434753,0.001589527,0.02258153,0.001355902,0.0003307701,0.00003742313,0.0004739996,0.001197422,0.0001469971],"category_scores_gemma":[0.010145,0.0009897732,0.006447995,0.004847447,0.0006108413,0.0001727068,0.0006464118,0.001776863,0.00003084578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009777454,"about_ca_system_score_gemma":0.0001620466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009724597,"about_ca_topic_score_gemma":0.0000618381,"domain_scores_codex":[0.9895707,0.002580435,0.004146872,0.00198681,0.0007299652,0.0009852218],"domain_scores_gemma":[0.9901116,0.004989904,0.002364618,0.001336117,0.0003990849,0.0007986045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00002932234,0.0002495803,0.001590675,0.7596486,0.222829,0.000008885308,0.000277409,0.000004001683,0.000001128181,0.000013065,0.0005695876,0.01477872],"study_design_scores_gemma":[0.001644952,0.0002567772,0.002289079,0.08130375,0.9040122,0.0000298996,0.0000869994,0.0003104404,2.02017e-7,0.00000861132,0.009184541,0.0008725502],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001325815,0.9896334,0.00002301171,0.001262169,0.0000775955,0.007963006,0.0008277587,0.000136255,0.00006357789],"genre_scores_gemma":[0.001499478,0.9948279,0.0006349239,0.0003440116,0.00005904813,0.001802964,0.0004630891,0.00016297,0.000205653],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6811832,"threshold_uncertainty_score":0.9996853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2195362151","doi":"10.1016/j.msard.2015.11.006","title":"Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Tolerability; Discontinuation; Adverse effect; Placebo; Internal medicine; Clinical trial; Nausea; Multiple sclerosis; Fingolimod; Immunology; Pathology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1248231933583505,"gpt":0.3203329941100626,"spread":0.1955098007517121,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001249788,0.0004337941,0.001360646,0.0001483063,0.0005048619,0.00008648893,0.0001771765,0.0002255301,0.00002961848],"category_scores_gemma":[0.006468188,0.000309161,0.00009183264,0.0002066734,0.0009491339,0.0003049101,0.001104128,0.0004583444,0.00001093745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007514754,"about_ca_system_score_gemma":0.00008370022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009947382,"about_ca_topic_score_gemma":0.001019324,"domain_scores_codex":[0.9968283,0.00031296,0.0007760248,0.001107869,0.0004499934,0.0005248757],"domain_scores_gemma":[0.996647,0.001438189,0.0001750271,0.0008881445,0.0002515078,0.0006001161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05340818,0.001207481,0.6809329,0.0005526623,0.009043436,0.00004326562,0.01288553,0.0001748635,0.02827644,0.00005193442,0.01074793,0.2026754],"study_design_scores_gemma":[0.07933719,0.0003774309,0.8757399,0.0006023434,0.0008145574,0.00001253466,0.008093211,0.03201941,0.00004154822,0.0003912351,0.002068979,0.0005016809],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9544169,0.03517253,0.00004682854,0.007443102,0.0002204608,0.001894998,0.0002148473,0.0001340424,0.0004563339],"genre_scores_gemma":[0.9503375,0.04767282,0.00127943,0.0001900704,0.00005594286,0.00007544598,0.0001180874,0.00004190363,0.0002288522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2021737,"threshold_uncertainty_score":0.999936,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281640815","doi":"10.1016/j.msard.2022.103932","title":"Multiple sclerosis incidence: A systematic review of change over time by geographical region","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Incidence (geometry); Demography; Medicine; Population; Multiple sclerosis; Scopus; McDonald criteria; Systematic review; Pediatrics; MEDLINE; Geography; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1116008434935732,"gpt":0.3133250691918504,"spread":0.2017242256982773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001762596,0.001369207,0.007568015,0.000931209,0.0006119516,0.00006537095,0.0007095737,0.0009333045,0.0008427887],"category_scores_gemma":[0.004759553,0.001027052,0.002344715,0.002515254,0.0008653709,0.0002602642,0.0009864027,0.00190519,0.00006539829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003379307,"about_ca_system_score_gemma":0.0001950912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006711896,"about_ca_topic_score_gemma":0.0000336271,"domain_scores_codex":[0.990769,0.001435841,0.00309552,0.001640498,0.001932687,0.0011264],"domain_scores_gemma":[0.993413,0.002333858,0.001851257,0.001572406,0.0002246775,0.0006048224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00006093588,0.0006685765,0.0005429904,0.8448969,0.002029775,0.000007921165,0.0002437194,1.792792e-7,0.00002908039,0.000002846771,0.005927888,0.1455892],"study_design_scores_gemma":[0.003084787,0.0004790412,0.0009553436,0.8653865,0.006845653,0.0000496166,0.0001102522,0.0003244835,0.000001542229,0.000003783397,0.121704,0.001054999],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001704073,0.9860152,0.000003327636,0.0003775475,0.0002157721,0.01230247,0.0005050662,0.0002059636,0.0002042241],"genre_scores_gemma":[0.001098817,0.9918265,0.00005283646,0.0002857795,0.00005614847,0.004973392,0.001110449,0.000258099,0.0003380316],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1445342,"threshold_uncertainty_score":0.9999059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005104380","doi":"10.1016/j.msard.2014.05.005","title":"First-dose effects of fingolimod: Pooled safety data from three phase 3 studies","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; National Research Foundation; Novartis","keywords":"Fingolimod; Medicine; Bradycardia; Cardiology; Heart rate; Internal medicine; Electrocardiography; Atrioventricular block; Anesthesia; Disopyramide; Multiple sclerosis; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.02777977866621691,"gpt":0.257610424226585,"spread":0.2298306455603681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002627767,0.000217121,0.0003534759,0.000044501,0.0001881709,0.000017373,0.0003031806,0.0001904038,0.00001087168],"category_scores_gemma":[0.0008363446,0.0001820881,0.00008749391,0.0001007019,0.0001776698,0.00001252836,0.000362523,0.0001100471,0.000003728232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003951828,"about_ca_system_score_gemma":0.00001488297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002400942,"about_ca_topic_score_gemma":0.0004908621,"domain_scores_codex":[0.9986765,0.00007821855,0.0003488938,0.0005324575,0.0001264812,0.0002374017],"domain_scores_gemma":[0.9988192,0.0002078462,0.0001522694,0.0006868124,0.000047569,0.00008635361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0007577501,0.0006084528,0.01846664,0.0002613731,0.001555506,9.15313e-7,0.000858817,0.001157479,0.9015161,0.0001011979,0.001168324,0.0735474],"study_design_scores_gemma":[0.1066486,0.002291757,0.3567339,0.002077724,0.002810145,0.000005463746,0.001745539,0.1777243,0.2782125,0.003726107,0.06477677,0.003247159],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757311,0.02111866,0.002135307,0.0001441681,0.0004066987,0.0002582539,0.0001003202,0.00002186473,0.000083577],"genre_scores_gemma":[0.9872413,0.01157652,0.0005317602,0.00008738779,0.0001051459,0.00001174613,0.0003926694,0.0000284712,0.00002496842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6233037,"threshold_uncertainty_score":0.7425336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3127226135","doi":"10.1016/j.msard.2021.102800","title":"COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Neuromyelitis optica; Multiple sclerosis; Demyelinating disease; Rituximab; Pandemic; Disease; Coronavirus disease 2019 (COVID-19); Demyelinating Disorder; Natalizumab; Intensive care medicine; Pediatrics; Immunology; Internal medicine; Infectious disease (medical specialty); Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.04458613880730145,"gpt":0.2984827912922994,"spread":0.253896652484998,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004765852,0.0006565457,0.003704685,0.0002343952,0.0003710798,0.00005568115,0.0002402732,0.0002112576,0.00001189606],"category_scores_gemma":[0.006597591,0.0003449211,0.000560479,0.000913171,0.0004820247,0.0000911508,0.0003456385,0.0005497392,8.111665e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003303923,"about_ca_system_score_gemma":0.0006592584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001932103,"about_ca_topic_score_gemma":0.00006702865,"domain_scores_codex":[0.9953355,0.001080336,0.001433234,0.0007700045,0.000806753,0.0005741589],"domain_scores_gemma":[0.9965318,0.0009817459,0.0008638392,0.0006981898,0.0001609487,0.0007634616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00004003388,0.000250743,0.05233771,0.9089077,0.0009700631,0.000005440042,0.0003390728,0.000007904736,1.360897e-7,0.00001516174,0.00004553978,0.0370805],"study_design_scores_gemma":[0.003118561,0.00007642435,0.09577359,0.8922987,0.006636184,0.000005405528,0.0006610983,0.000174261,2.052299e-8,0.000002247237,0.0008520474,0.0004014859],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001216056,0.990162,0.000004230089,0.0003820636,0.00007982735,0.007860877,0.0002270625,0.00005336225,0.00001450646],"genre_scores_gemma":[0.05252888,0.9463917,0.00003145969,0.0001226048,0.00001176968,0.0006732141,0.0001400842,0.00008010917,0.00002015068],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.05131283,"threshold_uncertainty_score":0.9999003,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2346221108","doi":"10.1016/j.msard.2016.05.006","title":"Adherence and persistence to drug therapies for multiple sclerosis: A population-based study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Saskatchewan Health Quality Council; University of British Columbia Hospital; Health Sciences Centre; Manitoba Health; University of Manitoba; University of Saskatchewan","funders":"Ministry of Health, British Columbia; National Multiple Sclerosis Society","keywords":"Medicine; Discontinuation; Persistence (discontinuity); Glatiramer acetate; Population; Multiple sclerosis; Demography; Internal medicine; Socioeconomic status; Pediatrics; Disease; Immunology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.06897687515609541,"gpt":0.2839010022949514,"spread":0.214924127138856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005800233,0.0004642333,0.0006730658,0.00032383,0.0007365945,0.00009734989,0.0001890499,0.0001567521,0.00006170863],"category_scores_gemma":[0.001789039,0.0003064288,0.0002051674,0.0004346509,0.0002686564,0.0002137931,0.0001658317,0.0002006334,0.00001693063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001082615,"about_ca_system_score_gemma":0.00005904818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009202519,"about_ca_topic_score_gemma":0.001940862,"domain_scores_codex":[0.9969347,0.0001576286,0.0006009819,0.001040209,0.0005442088,0.0007222953],"domain_scores_gemma":[0.9972843,0.001330946,0.0001517419,0.0005073008,0.0002541055,0.000471589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009225792,0.0007240137,0.8585194,0.0001131555,0.0003477309,7.833441e-7,0.003430433,0.00003936184,0.02422707,0.000008185705,0.0003624073,0.1113049],"study_design_scores_gemma":[0.01563451,0.001208082,0.9729794,0.0009685645,0.0001459946,8.618036e-7,0.005448244,0.002291592,0.0004071209,0.00003960326,0.0004126502,0.0004634364],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987308,0.001859462,0.0003148351,0.005738491,0.0001631014,0.004261581,0.0001138211,0.0001880075,0.0000526976],"genre_scores_gemma":[0.994914,0.001643884,0.001636989,0.000235582,0.00003965788,0.001054637,0.00001977803,0.0000750655,0.0003803957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.11446,"threshold_uncertainty_score":0.9999388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963477604","doi":"10.1016/j.msard.2015.07.014","title":"Comorbidity is associated with pain-related activity limitations in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary; McGill University; University of British Columbia; Dalhousie University; St. Francis Xavier University; University of Manitoba","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Health Research Foundation","keywords":"Medicine; Multiple sclerosis; Comorbidity; Physical medicine and rehabilitation; Physical therapy; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.159262001200248,"gpt":0.2815926175422206,"spread":0.1223306163419726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001854184,0.0006190228,0.0010129,0.0005488202,0.0005216337,0.0001069972,0.0002204881,0.000559488,0.00007940899],"category_scores_gemma":[0.007329229,0.0005087025,0.0002350168,0.001780177,0.0008627956,0.0004168863,0.0002223726,0.001157846,0.00005060582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004308832,"about_ca_system_score_gemma":0.0002304607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002086076,"about_ca_topic_score_gemma":0.006785884,"domain_scores_codex":[0.9953987,0.0007015194,0.0007810508,0.001031286,0.001022236,0.00106523],"domain_scores_gemma":[0.9959973,0.001879325,0.0003155491,0.0006081595,0.0004498653,0.0007498786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001194026,0.002962355,0.8809894,0.0000981139,0.001168872,0.00002189903,0.006998195,0.0008726054,0.009312894,0.0000149947,0.004246923,0.09211969],"study_design_scores_gemma":[0.0185794,0.0008364737,0.9277326,0.000951698,0.0001521765,0.000004923736,0.002674374,0.04699682,0.0005706429,0.0001084344,0.0007513185,0.0006411282],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882729,0.001159756,0.00006352055,0.005167462,0.0001755037,0.001778717,0.0001036117,0.0003231607,0.002955365],"genre_scores_gemma":[0.9931265,0.005139639,0.0003065375,0.0002627702,0.00002075998,0.0002408859,0.0001433294,0.000109389,0.0006502059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09147857,"threshold_uncertainty_score":0.9997365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096243634","doi":"10.1016/j.msard.2014.06.001","title":"CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute for Health and Care Research; University of Alberta","keywords":"CD20; Medicine; Flow cytometry; Immunology; Multiple sclerosis; Inflammation; Fas ligand; Apoptosis; Antigen; Programmed cell death; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02386338981250617,"gpt":0.2357481643270885,"spread":0.2118847745145824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006045724,0.0003965568,0.000729638,0.0004363916,0.0002984786,0.00004261186,0.0001015347,0.0002941051,0.000007954459],"category_scores_gemma":[0.002437371,0.0003542115,0.000117069,0.0003830555,0.0004885832,0.0001581669,0.0001712763,0.0003290905,5.817515e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006573705,"about_ca_system_score_gemma":0.00003951398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006748548,"about_ca_topic_score_gemma":0.001322806,"domain_scores_codex":[0.9972644,0.0002220795,0.0007025383,0.0007545491,0.0004547724,0.0006016757],"domain_scores_gemma":[0.9976193,0.001202138,0.0003207833,0.0002505764,0.0003190722,0.0002881465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000634251,0.001069373,0.781093,0.0008474953,0.0003821591,4.241031e-7,0.002964644,0.0001704309,0.1835432,0.00002059668,0.0004663107,0.02880813],"study_design_scores_gemma":[0.02058205,0.0007360766,0.9401092,0.0006417501,0.0001513415,6.621761e-7,0.0009751847,0.02056363,0.01569878,0.00004062029,0.0001552802,0.0003454385],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939034,0.0009647431,0.00004689286,0.00231274,0.00008554225,0.002433712,0.0001455606,0.0000556003,0.00005179216],"genre_scores_gemma":[0.9943776,0.004444041,0.0005832991,0.0001042589,0.0000240705,0.0002507364,0.00008770733,0.00006465338,0.00006364746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1678444,"threshold_uncertainty_score":0.999891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031617600","doi":"10.1016/j.msard.2013.07.001","title":"Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Glatiramer acetate; Clinically isolated syndrome; Placebo; Clinical trial; McDonald criteria; Natalizumab; Pediatrics; Fingolimod; Disease; Physical therapy; Internal medicine; Alternative medicine; Pathology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.450456436309058,"gpt":0.4949665737900651,"spread":0.04451013748100718,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005065041,0.0009374161,0.008436697,0.0004317259,0.0003094842,0.0000795536,0.0003136669,0.001646127,0.00005494419],"category_scores_gemma":[0.04816678,0.0006483716,0.002760424,0.0005100712,0.001191082,0.0002531138,0.0003270711,0.0008621826,0.00001189323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001159996,"about_ca_system_score_gemma":0.0004531282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001178354,"about_ca_topic_score_gemma":0.0000714522,"domain_scores_codex":[0.9883856,0.001987168,0.006764982,0.00161524,0.0005238414,0.0007232159],"domain_scores_gemma":[0.9549693,0.03957509,0.00312923,0.001005366,0.0006435151,0.0006774373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005676825,0.00207098,0.02522432,0.003279826,0.006001436,4.452664e-7,0.0005668999,0.000001097913,0.0001292992,0.00001433824,0.0009658834,0.9611778],"study_design_scores_gemma":[0.03621255,0.003649421,0.3513722,0.02650092,0.01759326,0.000009149298,0.001593585,0.000974837,0.00003485742,0.00007528348,0.5607238,0.001260101],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01869373,0.968563,0.000139089,0.001092264,0.0004139858,0.00933079,0.001605543,0.00007348755,0.00008810639],"genre_scores_gemma":[0.01987378,0.9683825,0.009039971,0.00004066494,0.0002062554,0.00176409,0.0004492176,0.0001553977,0.00008806359],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9599177,"threshold_uncertainty_score":0.9996499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2788304256","doi":"10.1016/j.msard.2018.02.019","title":"A survey of dietary characteristics in a large population of people with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Medicine; Population; Environmental health; Gerontology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.04848958074081954,"gpt":0.2718305457115136,"spread":0.2233409649706941,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008573669,0.0003335175,0.001017659,0.0004215292,0.0001804309,0.00001636863,0.0001384614,0.0002394661,0.00007953681],"category_scores_gemma":[0.001635739,0.0002632743,0.0001216831,0.001191108,0.0004969603,0.0001622164,0.0001730782,0.0003347569,0.000005713762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005828135,"about_ca_system_score_gemma":0.00006351968,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01402651,"about_ca_topic_score_gemma":0.03317649,"domain_scores_codex":[0.9971375,0.0002344996,0.0009453406,0.0005471911,0.0005600156,0.0005754075],"domain_scores_gemma":[0.9979833,0.0005278578,0.0003950925,0.0004530562,0.0004558316,0.0001847975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001512572,0.0009648718,0.9686723,0.0002600036,0.0002371944,7.556229e-7,0.002101889,0.00001204882,0.01322488,0.000003738346,0.00004636031,0.0129634],"study_design_scores_gemma":[0.008803289,0.0009165056,0.9744163,0.001068585,0.00007940905,0.000001316219,0.0005504725,0.01337835,0.0005029495,0.000005145482,0.00001594393,0.000261756],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975005,0.0006340597,0.00004245618,0.0001887678,0.00009920506,0.001018855,0.000325209,0.0000444381,0.0001464416],"genre_scores_gemma":[0.9953486,0.00373184,0.0004002477,0.00002587233,0.00002108123,0.00005572621,0.0003281547,0.00005640985,0.00003206246],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01914998,"threshold_uncertainty_score":0.9999819,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4206573422","doi":"10.1016/j.msard.2022.103535","title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Canadian Electricity Association; University of Manitoba; Ottawa Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Biomarker; Proportional hazards model; Internal medicine; Oncology; McDonald criteria; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.04458607865476119,"gpt":0.2648251562306154,"spread":0.2202390775758542,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001131944,0.0005991445,0.001153789,0.000648922,0.001623431,0.00006335607,0.0003566223,0.0002678493,0.001498398],"category_scores_gemma":[0.002125876,0.0004996096,0.0004085597,0.001381738,0.0007178786,0.000324815,0.001117177,0.001119571,0.00001516442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003214914,"about_ca_system_score_gemma":0.0001802632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003208303,"about_ca_topic_score_gemma":0.0002432938,"domain_scores_codex":[0.9949089,0.0005094011,0.001139665,0.001108737,0.001306766,0.001026555],"domain_scores_gemma":[0.9967039,0.001428545,0.000490897,0.0007046413,0.0002309024,0.0004410796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009136474,0.002139729,0.7752137,0.0006134757,0.002602431,0.00002282309,0.009913809,0.001975274,0.1219877,0.00007590128,0.004518152,0.07180049],"study_design_scores_gemma":[0.01845079,0.001983203,0.9412578,0.0009673692,0.000456465,0.0000414795,0.01262636,0.01572159,0.006124794,0.0001018752,0.001508628,0.0007596524],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991203,0.002688484,0.00004306874,0.001945708,0.0004831612,0.001791274,0.0008235637,0.0002516092,0.0007701505],"genre_scores_gemma":[0.9859939,0.01146137,0.001132976,0.0002234753,0.00005930378,0.0003489193,0.0001189189,0.0001350765,0.0005260363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1660441,"threshold_uncertainty_score":0.9997455,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2765282886","doi":"10.1016/j.msard.2017.11.003","title":"The prevalence of anxiety and associated factors in persons with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"UCB Pharma; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Canada Research Chairs; Alberta Health; Cumming School of Medicine, University of Calgary; University of Calgary; Alberta Health Services","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Medicine; Depression (economics); Quality of life (healthcare); Confounding; Odds ratio; Cross-sectional study; Psychiatry; Population; Multiple sclerosis; Logistic regression; Clinical psychology; Odds; Internal medicine; Environmental health; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03697108856239301,"gpt":0.2572941627361175,"spread":0.2203230741737245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006282513,0.0003668288,0.0005357384,0.0001947161,0.0007151684,0.00005692437,0.0001795863,0.0002430739,0.00004132167],"category_scores_gemma":[0.001642072,0.0002233579,0.0001185723,0.0007310571,0.002047526,0.0001711216,0.0002002275,0.0004855682,0.000003076248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008333017,"about_ca_system_score_gemma":0.00006704247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001247426,"about_ca_topic_score_gemma":0.004234795,"domain_scores_codex":[0.9973939,0.0001884571,0.0005309433,0.0006355693,0.0005586299,0.0006924936],"domain_scores_gemma":[0.998017,0.0008838887,0.0002237256,0.0004099254,0.0002241767,0.0002412855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004371096,0.0002957929,0.9686085,0.0001639856,0.0002883114,4.907774e-7,0.003722779,0.000008713363,0.0142867,0.000008716826,0.0001855946,0.01199332],"study_design_scores_gemma":[0.006542421,0.0006092688,0.9821357,0.0008839459,0.0001213485,0.000002141918,0.003204439,0.00436806,0.001535783,0.00001115806,0.0003203488,0.0002653735],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946269,0.002622033,0.000007844909,0.0008793976,0.00008330413,0.001064757,0.00009307081,0.00007069208,0.0005519858],"genre_scores_gemma":[0.9676737,0.03165077,0.0001405496,0.00003060085,0.00001677235,0.00006755268,0.00001309172,0.00004699251,0.0003600158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02902874,"threshold_uncertainty_score":0.9108272,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2787599611","doi":"10.1016/j.msard.2018.01.021","title":"Physical activity and disability outcomes in multiple sclerosis: A systematic review (2011–2016)","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Physical therapy; Physical medicine and rehabilitation; Adverse effect; Rehabilitation; MEDLINE; Balance (ability); Multiple sclerosis","retraction":null,"screen_n_in":null,"score":{"opus":0.09789177387970635,"gpt":0.3365683771397416,"spread":0.2386766032600352,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001652945,0.001570332,0.008857496,0.0003923473,0.0004893018,0.0001228792,0.0004421489,0.0008389475,0.00006471436],"category_scores_gemma":[0.005306087,0.001035331,0.001444232,0.0008333401,0.001932017,0.0003196564,0.0008177589,0.001678166,0.0001656116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004299113,"about_ca_system_score_gemma":0.0001921278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008680621,"about_ca_topic_score_gemma":0.0006540061,"domain_scores_codex":[0.9924062,0.00135558,0.00190337,0.002079564,0.001004732,0.001250488],"domain_scores_gemma":[0.99376,0.002867953,0.0009155047,0.001631904,0.0001774365,0.0006472207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000729462,0.002083614,0.006018157,0.7671279,0.001604336,0.000004216582,0.0003331556,2.476193e-7,0.00001734219,0.000003100309,0.000391839,0.2223431],"study_design_scores_gemma":[0.005727525,0.0004377188,0.06408009,0.9153351,0.006146063,0.0000210733,0.0002081904,0.0008009458,0.000002876871,0.00001860487,0.005660339,0.001561448],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01502555,0.971683,0.00000298632,0.0006311788,0.0002120932,0.01189368,0.0002367087,0.0001969123,0.0001178433],"genre_scores_gemma":[0.04540299,0.9514217,0.0000737948,0.00007061087,0.00006619294,0.002459113,0.00009151807,0.000184988,0.0002290794],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2207817,"threshold_uncertainty_score":0.9997045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2175178720","doi":"10.1016/j.msard.2015.10.007","title":"Spasticity in multiple sclerosis: Associations with impairments and overall quality of life","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux; Biogen","keywords":"Spasticity; Medicine; Depression (economics); Anxiety; Quality of life (healthcare); Multiple sclerosis; Physical therapy; Hospital Anxiety and Depression Scale; Mood; Physical medicine and rehabilitation; Visual analogue scale; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1009037667304505,"gpt":0.2992243905898357,"spread":0.1983206238593851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001006193,0.0003453188,0.0008867348,0.000286151,0.0001797333,0.00004295983,0.0001094046,0.0002473446,0.00001941908],"category_scores_gemma":[0.00358505,0.0002719594,0.0001103575,0.0005126451,0.0005560551,0.000240292,0.0002051805,0.0004591466,0.000005259876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001546974,"about_ca_system_score_gemma":0.0001699208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004952364,"about_ca_topic_score_gemma":0.00297253,"domain_scores_codex":[0.9969582,0.0002720318,0.0008432973,0.0005912127,0.0007533958,0.0005818647],"domain_scores_gemma":[0.9978911,0.000603737,0.0003217439,0.0003298945,0.0002781787,0.0005753578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009634619,0.0009249065,0.9852791,0.0001362598,0.0003568367,0.000001332221,0.002293991,0.0004028899,0.005508172,0.00002065907,0.0002652299,0.003847172],"study_design_scores_gemma":[0.0219997,0.0005120072,0.9688355,0.0004590817,0.00007199161,0.000001306624,0.002163539,0.005408585,0.0001467106,0.00006886438,0.00004362515,0.0002891025],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951535,0.001728187,0.00004632386,0.00121045,0.00007264536,0.001101551,0.0001162685,0.00007412213,0.00049691],"genre_scores_gemma":[0.9959275,0.002888458,0.0008080035,0.0001080798,0.0000195777,0.00008922354,0.00005340476,0.00004225575,0.00006355836],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02103624,"threshold_uncertainty_score":0.9999732,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2935354372","doi":"10.1016/j.msard.2019.04.003","title":"Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi; Genzyme","keywords":"Multiple sclerosis; Medicine; Pregnancy; Disease; Postpartum period; Intensive care medicine; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0732434747957501,"gpt":0.2737825918765738,"spread":0.2005391170808237,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007335737,0.000800201,0.002425722,0.0002664569,0.0003018248,0.00004668647,0.0004591579,0.0006312187,0.00006481825],"category_scores_gemma":[0.0001850411,0.0005590928,0.0006505486,0.0004401046,0.0004490168,0.0004551144,0.0001247532,0.0004149211,0.00004477145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005687143,"about_ca_system_score_gemma":0.0001821448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001262199,"about_ca_topic_score_gemma":0.00002078173,"domain_scores_codex":[0.9954076,0.0008029268,0.001285612,0.001802138,0.0001491236,0.0005526055],"domain_scores_gemma":[0.9966397,0.0003124705,0.001313187,0.001345602,0.0003339981,0.00005505272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000366489,0.0008749074,0.001206849,0.1143854,0.00256608,8.977722e-7,0.0003044425,0.00009742671,0.00009937141,0.00008452515,0.0004338216,0.8795798],"study_design_scores_gemma":[0.01351571,0.003774482,0.01080502,0.7623891,0.0121911,0.000014467,0.001919985,0.00001444293,0.0001191175,0.00007554936,0.1924854,0.002695557],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007814161,0.9890038,0.0001201335,0.00004378721,0.0009256675,0.008564511,0.0003243947,0.00007820282,0.0001580443],"genre_scores_gemma":[0.04467228,0.9524834,0.000220006,0.00001910515,0.00002434888,0.001038022,0.001071199,0.0001071257,0.0003645149],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8768842,"threshold_uncertainty_score":0.9996861,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283516981","doi":"10.1016/j.msard.2022.103995","title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Université de Sherbrooke; University of British Columbia; Memorial University of Newfoundland; Western University","funders":"","keywords":"Natalizumab; Medicine; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Dosing; Adverse effect; Intensive care medicine; Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.07109589134726166,"gpt":0.2656694784780308,"spread":0.1945735871307691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002441602,0.0008732226,0.00249415,0.0009049656,0.000325018,0.00005784578,0.0002647083,0.0007559002,0.0006964574],"category_scores_gemma":[0.0002779072,0.000633389,0.0008255314,0.001545236,0.0004926266,0.000234592,0.0002750145,0.001493567,0.00001882462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001999002,"about_ca_system_score_gemma":0.0004165338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00148664,"about_ca_topic_score_gemma":0.0003622315,"domain_scores_codex":[0.9959857,0.000324252,0.001254488,0.001078681,0.0006309732,0.0007258953],"domain_scores_gemma":[0.9975998,0.0005154502,0.0006792936,0.0007643105,0.00004311396,0.0003979797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008167009,0.001784398,0.005196963,0.007477839,0.002147076,0.00008781832,0.0005075173,0.0001178198,0.00002103995,0.00003237495,0.001089031,0.9807214],"study_design_scores_gemma":[0.009454138,0.0007143983,0.004615321,0.03082879,0.004676375,0.0001012232,0.0007598922,0.0009432558,0.000004014163,0.000007834959,0.9466426,0.001252208],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009731608,0.9865528,0.000002137774,0.0000903507,0.0002546575,0.002020706,0.0009839509,0.0001210574,0.0002427411],"genre_scores_gemma":[0.01977831,0.9778824,0.0001200781,0.00005728609,0.00001856715,0.0003702914,0.001155978,0.0002070382,0.0004100251],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9794692,"threshold_uncertainty_score":0.9996117,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1551155942","doi":"10.1016/j.msard.2015.05.009","title":"Neurologists׳ accuracy in predicting cognitive impairment in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Cognitive impairment; Cognition; Physical medicine and rehabilitation; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.08852712692423444,"gpt":0.2958466182721283,"spread":0.2073194913478939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001205283,0.0005347912,0.0008617697,0.0007116506,0.0002384301,0.00008085917,0.0002050775,0.0003925294,0.00004705127],"category_scores_gemma":[0.007751945,0.0004649884,0.0001889206,0.001193883,0.000599799,0.0003784604,0.0004302593,0.001131927,0.00004329299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002801784,"about_ca_system_score_gemma":0.0001602932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004467925,"about_ca_topic_score_gemma":0.004503245,"domain_scores_codex":[0.9956099,0.0003836925,0.001031824,0.001060753,0.0007545748,0.001159275],"domain_scores_gemma":[0.997108,0.001478944,0.0002306687,0.0003924679,0.0002051606,0.0005847972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001521048,0.001223305,0.9570152,0.00009414134,0.0001314974,0.00002807167,0.004058935,0.0006109261,0.002496491,0.00000360063,0.0002428181,0.03257397],"study_design_scores_gemma":[0.02773827,0.0007804072,0.9302762,0.001124805,0.00005747971,0.000008922497,0.005162875,0.03394417,0.0002846599,0.00004888463,0.000150816,0.0004225051],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908069,0.002715502,0.00001886456,0.0023989,0.0002525125,0.002386084,0.0000535476,0.000186936,0.001180727],"genre_scores_gemma":[0.9901637,0.008692775,0.0002323717,0.0002485646,0.00004622241,0.0004003562,0.00007583907,0.00007811138,0.00006207144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03333324,"threshold_uncertainty_score":0.9997802,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2077138786","doi":"10.1016/j.msard.2012.08.001","title":"Cognitive and neuropsychiatric disease manifestations in MS","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Cognition; Psychiatry; Disease; Cognitive impairment; Mental health; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0799669021878602,"gpt":0.3268902966310698,"spread":0.2469233944432096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003030465,0.0006150917,0.001366553,0.0007437414,0.0002832182,0.00005644682,0.00009926181,0.0003393554,0.00008117458],"category_scores_gemma":[0.0007218517,0.0004754608,0.0003274272,0.0008026114,0.000438207,0.0001512992,0.0002304067,0.0009731357,0.00005195408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006905387,"about_ca_system_score_gemma":0.0001427096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002207671,"about_ca_topic_score_gemma":0.0001967947,"domain_scores_codex":[0.9970369,0.0003162237,0.0007834945,0.0008029296,0.0003700195,0.0006904697],"domain_scores_gemma":[0.9979441,0.0008028242,0.0002379668,0.000297847,0.0000717818,0.0006455427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00007694973,0.00048338,0.0265097,0.00857656,0.0003456235,0.00001673115,0.0003689296,7.084626e-7,9.468296e-7,0.00001662142,0.00008282323,0.963521],"study_design_scores_gemma":[0.006974605,0.0001988577,0.7981669,0.02534251,0.004189149,0.00004210503,0.0005458526,0.0003254164,6.023021e-8,0.00003742868,0.1631728,0.00100425],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004179331,0.9915704,0.000003280709,0.0002672774,0.000210695,0.002711577,0.0001991795,0.00007731388,0.0007809173],"genre_scores_gemma":[0.04223209,0.9565241,0.00006055942,0.00003830939,0.00006378104,0.0004227709,0.0002908016,0.0001086434,0.0002589916],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9625168,"threshold_uncertainty_score":0.9997697,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2890102036","doi":"10.1016/j.msard.2018.09.008","title":"Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Manitoba Health; Dalhousie University; University of Calgary; University of Manitoba; University of Toronto","funders":"Crohn's and Colitis Canada; Canadian Institutes of Health Research; Dalhousie University; Research Manitoba","keywords":"Medicine; Fingolimod; Adverse effect; Natalizumab; Psychiatry; Depression (economics); Anxiety; Meta-analysis; Relative risk; Incidence (geometry); Systematic review; Observational study; MEDLINE; Internal medicine; Multiple sclerosis; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.06242617778613777,"gpt":0.3091988898515426,"spread":0.2467727120654048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001349692,0.001398497,0.007099029,0.001276023,0.0003756997,0.00004622161,0.0005725734,0.0007093507,0.00004428361],"category_scores_gemma":[0.004894797,0.0009873849,0.00194227,0.002293347,0.0008322675,0.0002166438,0.0004282672,0.001188544,0.00008145339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002685538,"about_ca_system_score_gemma":0.0003300752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002060925,"about_ca_topic_score_gemma":0.0001298962,"domain_scores_codex":[0.9918116,0.001250378,0.003143707,0.001544715,0.001127746,0.001121891],"domain_scores_gemma":[0.993782,0.002311784,0.001511916,0.001526239,0.0002575111,0.000610503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001208978,0.0007882289,0.001411065,0.9427503,0.001871207,0.000007990948,0.0004152203,0.000002112455,0.00001067238,0.000004863686,0.0004631903,0.05215428],"study_design_scores_gemma":[0.006040044,0.0003692825,0.006628412,0.9710667,0.008199449,0.000006657958,0.0002194363,0.0003174001,0.000001487875,0.00001420305,0.006171908,0.000965048],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007323006,0.9830818,0.00001074338,0.0002105815,0.000433479,0.0151592,0.000109765,0.000158963,0.0001031516],"genre_scores_gemma":[0.01179616,0.9843661,0.0002649374,0.00009942828,0.00006846209,0.002902485,0.0001530208,0.0002355505,0.0001139284],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.05118923,"threshold_uncertainty_score":0.9998766,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2890349017","doi":"10.1016/j.msard.2018.09.002","title":"Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Multiple sclerosis; Family medicine; MEDLINE; Health care; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.06507269190061979,"gpt":0.2886625042213579,"spread":0.2235898123207381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006631003,0.0005414129,0.0007977016,0.0002734004,0.001318094,0.0001230169,0.0002845421,0.0002637578,0.00007677118],"category_scores_gemma":[0.001466981,0.0003765066,0.0001427424,0.0008194853,0.001379958,0.0002310138,0.0005615342,0.0008918907,0.00004027774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002157796,"about_ca_system_score_gemma":0.0001406574,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01767401,"about_ca_topic_score_gemma":0.01711324,"domain_scores_codex":[0.9953675,0.00098688,0.0009018198,0.001155455,0.0007227361,0.000865561],"domain_scores_gemma":[0.9968467,0.001301645,0.0003284809,0.0008206003,0.0002668936,0.0004356512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005060546,0.0004321079,0.8308147,0.0001591901,0.0003538808,0.000002394503,0.02903145,0.0000237625,0.0012019,0.000006056615,0.004851966,0.1326165],"study_design_scores_gemma":[0.006972939,0.0009107159,0.9775589,0.001245185,0.00006685604,0.000001124347,0.006084329,0.002464477,0.0001052496,0.00001545361,0.004170665,0.0004040773],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9585162,0.03531319,0.00001579898,0.0025838,0.000330629,0.002318898,0.0003340252,0.0001172426,0.0004702552],"genre_scores_gemma":[0.9210966,0.07727513,0.0003108115,0.0007016363,0.00006505364,0.0001917552,0.0002396073,0.0000669096,0.00005255842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1467443,"threshold_uncertainty_score":0.9999821,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2906840863","doi":"10.1016/j.msard.2019.01.003","title":"Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Hospitalier de l’Université de Montréal","funders":"National Medical Research Council; National Health and Medical Research Council","keywords":"Medicine; Multiple sclerosis; Incidence (geometry); Cohort; Pregnancy; Disease; Cohort study; Pediatrics; Environmental health; Demography; Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.04406432906042038,"gpt":0.270324932803981,"spread":0.2262606037435606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006075947,0.0005061951,0.001079478,0.0005869046,0.0002024781,0.00005521442,0.0001854191,0.000181228,0.00007745746],"category_scores_gemma":[0.0003268982,0.0003737809,0.0001027163,0.0009331868,0.0004826124,0.0003688465,0.0002181566,0.0005162671,0.000004166954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001036371,"about_ca_system_score_gemma":0.0001256702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001044135,"about_ca_topic_score_gemma":0.0003638221,"domain_scores_codex":[0.9964408,0.0002582197,0.0007870957,0.001039012,0.0007867428,0.0006880941],"domain_scores_gemma":[0.9980446,0.0003655428,0.0002757153,0.0006570208,0.000150112,0.0005069854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00369751,0.001540733,0.9224657,0.0002015383,0.0005546194,0.0000100502,0.007139443,0.0001006876,0.00566203,0.000001867904,0.00003282768,0.05859302],"study_design_scores_gemma":[0.02753831,0.002105472,0.956995,0.002959276,0.00005325555,0.000001717799,0.007840134,0.001991404,0.00006895282,0.00001157942,0.00002826705,0.0004066423],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979863,0.01576077,0.000004380176,0.0003721038,0.00006633271,0.003433204,0.00003981591,0.00008999721,0.0003704322],"genre_scores_gemma":[0.9828469,0.01602006,0.00008908106,0.00005906346,0.00001032453,0.0007171354,0.00002355678,0.00007608351,0.0001578127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05818638,"threshold_uncertainty_score":0.9998714,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2897720855","doi":"10.1016/j.msard.2018.10.018","title":"Diabetes and anxiety adversely affect cognition in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; University of Calgary; Health Sciences Centre; University of Manitoba","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Nova Scotia Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Natural Sciences and Engineering Research Council of Canada; Fondation Brain Canada; Health Sciences Centre Foundation; Brain and Behavior Research Foundation","keywords":"Medicine; Multiple sclerosis; Affect (linguistics); Cognition; Anxiety; Diabetes mellitus; Clinical psychology; Psychiatry; Endocrinology; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.04239819271777926,"gpt":0.2591488063774749,"spread":0.2167506136596957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006452239,0.000480794,0.0006983771,0.0004491184,0.0005886233,0.0000864094,0.0001222772,0.0003766324,0.0001408885],"category_scores_gemma":[0.001237669,0.000414708,0.0001727741,0.0007226527,0.001307984,0.0003265508,0.0002672943,0.0005678425,0.00005980603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008900841,"about_ca_system_score_gemma":0.00004405828,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004287895,"about_ca_topic_score_gemma":0.00141957,"domain_scores_codex":[0.9968324,0.0002025386,0.0005859426,0.0009603818,0.000492164,0.0009265926],"domain_scores_gemma":[0.9984067,0.0004902294,0.000144403,0.0003770246,0.0001780757,0.0004035704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003914183,0.0004473898,0.8020644,0.0001801766,0.0002691622,0.000001402535,0.001348585,0.000009100924,0.09118514,0.000008894329,0.0006831214,0.1034112],"study_design_scores_gemma":[0.01285453,0.0006136395,0.9657342,0.001032356,0.0001385398,0.000003610576,0.001151082,0.01269537,0.004322331,0.00006140245,0.0009178701,0.000475091],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992635,0.002616123,0.00001581724,0.001108981,0.0002112625,0.001483164,0.0000601511,0.000187756,0.001681823],"genre_scores_gemma":[0.9770607,0.02168663,0.0005027965,0.0002287945,0.00008435928,0.0001865484,0.00007324381,0.00007370836,0.000103184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1636698,"threshold_uncertainty_score":0.9998305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1676731399","doi":"10.1016/j.msard.2015.09.002","title":"Relapses in multiple sclerosis: Relationship to disability","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Biogen; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Clinical trial; Intensive care medicine; Pediatrics; Physical disability; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1861997059450834,"gpt":0.3503000033506756,"spread":0.1641002974055922,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.002019944,0.001381496,0.004114327,0.0009645455,0.0005489322,0.0001523878,0.0005221764,0.001436264,0.0001029559],"category_scores_gemma":[0.008871927,0.00110663,0.0009885024,0.0027443,0.001030724,0.0003095135,0.0008110743,0.002402661,0.0003765401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001083154,"about_ca_system_score_gemma":0.0004348843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084292,"about_ca_topic_score_gemma":0.002025394,"domain_scores_codex":[0.9918543,0.0009181414,0.002382214,0.002138894,0.001225352,0.001481088],"domain_scores_gemma":[0.9940447,0.002405551,0.000494356,0.001522551,0.0002667111,0.001266091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002428876,0.001116693,0.07131924,0.006898045,0.0004976164,0.000007603252,0.00112194,0.00005441546,0.00001061108,0.0000214118,0.002620707,0.9160888],"study_design_scores_gemma":[0.009836145,0.0006117394,0.2669837,0.05008424,0.001330397,0.00002187575,0.001313064,0.0004904257,0.000001872993,0.0001222105,0.6672335,0.001970893],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009186916,0.9805167,0.000008826918,0.001013537,0.000511007,0.006901388,0.0002978796,0.0003306201,0.001233064],"genre_scores_gemma":[0.08288229,0.9136903,0.0006119329,0.00006551727,0.0001079965,0.001511189,0.0004079211,0.0002497448,0.0004730827],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9141179,"threshold_uncertainty_score":0.9998989,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"grok","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2898257974","doi":"10.1016/j.msard.2018.10.109","title":"Coexistence of Multiple Sclerosis and Alzheimer's disease: A review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; International Collaboration On Repair Discoveries; Vancouver Coastal Health; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Genentech; Multiple Sclerosis Society; Michael Smith Health Research BC; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Novartis; Multiple Sclerosis Society of Canada; American Academy of Neurology; National Multiple Sclerosis Society Michigan Chapter; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Alzheimer's disease; Neuroscience; Dermatology; Pathology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1269058069483825,"gpt":0.3355699256097763,"spread":0.2086641186613938,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009827164,0.001292237,0.00460629,0.0005265457,0.000521034,0.00007335433,0.000455346,0.0006896293,0.0001831734],"category_scores_gemma":[0.002855295,0.0009674057,0.001234387,0.001206037,0.002229704,0.0002080126,0.000807812,0.0010419,0.00006836342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000100887,"about_ca_system_score_gemma":0.0003244485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002537137,"about_ca_topic_score_gemma":0.00007956813,"domain_scores_codex":[0.9935082,0.0005267355,0.002116123,0.001756492,0.001048868,0.001043608],"domain_scores_gemma":[0.9949151,0.001242094,0.001048723,0.001338456,0.0004098432,0.001045742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001524855,0.0005047436,0.002123172,0.0773656,0.002561956,0.000006988389,0.0001993217,4.815686e-7,0.00002085062,0.00001047351,0.005011505,0.9120424],"study_design_scores_gemma":[0.004516175,0.0004789781,0.01914644,0.3400458,0.009918937,0.00002489404,0.0001284937,0.0003395679,0.000005067327,0.00001506672,0.6240746,0.001306094],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003169996,0.9923598,0.000004437919,0.0005547323,0.0002660408,0.005284094,0.0005608417,0.00015972,0.0004933061],"genre_scores_gemma":[0.005170221,0.992672,0.0004386601,0.0001454605,0.00009528412,0.0006954014,0.0003790513,0.0002142035,0.0001896618],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9107363,"threshold_uncertainty_score":0.999983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966050297","doi":"10.1016/j.msard.2015.02.002","title":"Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Dysautonomia; Medicine; Multiple sclerosis; Meta-analysis; Internal medicine; Cardiology; Physical therapy; Disease; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1893393426216468,"gpt":0.3155923395924298,"spread":0.1262529969707829,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00286204,0.00168595,0.01219852,0.002780473,0.0004297511,0.0001848088,0.0004797768,0.001481907,0.0003008873],"category_scores_gemma":[0.001241464,0.001245336,0.01168465,0.004167502,0.0006335042,0.000306327,0.000582375,0.001993411,0.0002447568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008315656,"about_ca_system_score_gemma":0.000482794,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003017935,"about_ca_topic_score_gemma":0.001472744,"domain_scores_codex":[0.9908944,0.001223223,0.002484088,0.002488583,0.001502507,0.001407179],"domain_scores_gemma":[0.9953672,0.0008069106,0.0006995646,0.002002368,0.0003193674,0.0008045305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00009137804,0.0005041281,0.0007229226,0.003047554,0.3371452,0.00001200449,0.0003347928,0.0009095079,0.000005865339,0.000001572848,0.0004835038,0.6567415],"study_design_scores_gemma":[0.006978125,0.0002131529,0.005512379,0.002417688,0.5010164,0.00001271182,0.0003645515,0.003147872,0.000001423261,0.00001351169,0.4789126,0.001409596],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006869429,0.9929586,0.00003513128,0.0001916656,0.0003033078,0.004627991,0.0003921345,0.0002770749,0.0005271524],"genre_scores_gemma":[0.01688175,0.9789607,0.0003665793,0.00004048342,0.00008273673,0.002070046,0.000921384,0.0002561254,0.0004201976],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6553319,"threshold_uncertainty_score":0.9998144,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1964237140","doi":"10.1016/j.msard.2012.08.004","title":"Substantial burden of dizziness in multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Vestibular and auditory disorders","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Interquartile range; Confidence interval; Odds ratio; Quality of life (healthcare); Physical therapy; Multiple sclerosis; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.04611344163085638,"gpt":0.2295810488144897,"spread":0.1834676071836334,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002941757,0.0003225341,0.0004140667,0.0002646332,0.000246705,0.00003887624,0.000274387,0.0002568804,0.0001117547],"category_scores_gemma":[0.0007463057,0.0002952535,0.0001453241,0.0007918697,0.0004884932,0.00049743,0.0001261253,0.0003269818,0.00004006051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002936756,"about_ca_system_score_gemma":0.00002571218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006471672,"about_ca_topic_score_gemma":0.0001866242,"domain_scores_codex":[0.9976221,0.0002033039,0.0005864472,0.0005188725,0.0003555375,0.0007136978],"domain_scores_gemma":[0.9988423,0.0003845127,0.0002124807,0.0003222566,0.00002828655,0.0002101399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002130831,0.0009338381,0.3063423,0.00008552669,0.00003499896,0.000001870441,0.004856269,0.008049707,0.6518279,0.0002773202,0.0002174321,0.02715973],"study_design_scores_gemma":[0.01753346,0.0002860505,0.8255183,0.0008111746,0.0001303752,0.00001181837,0.004284588,0.03292751,0.1128801,0.0004826644,0.003283259,0.001850694],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99586,0.001493316,0.0001286735,0.000265209,0.0008901461,0.0004394704,0.0000445921,0.00009216647,0.0007863895],"genre_scores_gemma":[0.9971629,0.002448219,0.00009796024,0.0000570245,0.00006415308,0.00003382939,0.00001155814,0.00005271761,0.00007166748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5389478,"threshold_uncertainty_score":0.9999499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150843744","doi":"10.1016/j.msard.2015.03.005","title":"Impact of multiple sclerosis relapse: The NARCOMS participant perspective","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; University of Alabama at Birmingham; Cleveland Clinic","keywords":"Medicine; Weakness; Adverse effect; Socioeconomic status; Multiple sclerosis; Physical therapy; Pediatrics; Internal medicine; Psychiatry; Population; Surgery; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1198521864870689,"gpt":0.3271546963464877,"spread":0.2073025098594189,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001040613,0.0005237715,0.0009284568,0.0002776073,0.0004850754,0.00006806933,0.0003126855,0.0002967562,0.0001074768],"category_scores_gemma":[0.004055515,0.0003163914,0.0006128952,0.0009508752,0.001433198,0.0002371058,0.0003755413,0.0007787053,0.000048642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003250872,"about_ca_system_score_gemma":0.000274542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005828563,"about_ca_topic_score_gemma":0.0005574859,"domain_scores_codex":[0.9961491,0.0003413973,0.0008407489,0.0007642246,0.0009494343,0.0009551072],"domain_scores_gemma":[0.9967791,0.0006861945,0.0003148935,0.0008366967,0.0006872309,0.0006958974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0027055,0.002253009,0.885471,0.0001152847,0.003543474,0.000007467233,0.02726519,0.002022739,0.04298149,0.0002479292,0.007933807,0.02545305],"study_design_scores_gemma":[0.01270964,0.001430852,0.9550571,0.00044904,0.0003590093,0.00001221829,0.01577869,0.01253903,0.0006104377,0.0002329545,0.0003958218,0.0004252399],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843867,0.008099242,0.00003985392,0.003580988,0.0002326443,0.001587014,0.00008998924,0.0001503365,0.001833193],"genre_scores_gemma":[0.9915591,0.00749701,0.0002772101,0.00006536196,0.00006215546,0.0001706673,0.00002765057,0.00008243523,0.0002584383],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06958599,"threshold_uncertainty_score":0.9999288,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2548283306","doi":"10.1016/j.msard.2016.10.011","title":"The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Placebo; Crossover study; Randomized controlled trial; Physical therapy; Multiple sclerosis; Paced Auditory Serial Addition Test; Cognition; Physical medicine and rehabilitation; Internal medicine; Cognitive impairment; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.0345651191694123,"gpt":0.2910974223698583,"spread":0.256532303200446,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001267032,0.0003286265,0.001061491,0.0002946079,0.0001706563,0.00003019977,0.0001094282,0.000190764,0.00002886088],"category_scores_gemma":[0.003045157,0.0001386104,0.000204835,0.0004720575,0.001003892,0.0001112437,0.00008675645,0.0003598247,0.000006085213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007684229,"about_ca_system_score_gemma":0.00004114978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004533443,"about_ca_topic_score_gemma":0.00066999,"domain_scores_codex":[0.9972232,0.0004822894,0.0007105989,0.0004763,0.000606967,0.0005006639],"domain_scores_gemma":[0.9940261,0.005234155,0.0002378475,0.0002580413,0.0001240914,0.0001197719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7659848,0.0004063506,0.2120896,0.00004266892,0.0003044468,7.68443e-7,0.0003835291,0.00001778081,0.0002015334,0.000008767639,0.00001751984,0.0205422],"study_design_scores_gemma":[0.7003028,0.001999389,0.2951883,0.001436944,0.0000671098,7.949955e-8,0.00006222176,0.0001236118,0.0006585586,0.000008027783,0.0000135278,0.000139424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911286,0.0004381102,0.000009460109,0.0005558557,0.0001198493,0.007057131,0.0000254606,0.00002206545,0.0006434835],"genre_scores_gemma":[0.9956198,0.003524039,0.000007494038,0.00001485549,0.00001495271,0.0006802019,0.00001778624,0.00003476376,0.0000861306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0830987,"threshold_uncertainty_score":0.5652366,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2776489476","doi":"10.1016/j.msard.2017.12.012","title":"Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; University of British Columbia","funders":"","keywords":"Medicine; Neuromyelitis optica; Cancer; Serous fluid; Pathology; Serous carcinoma; Ovarian cancer; Serology; Oncology; Multiple sclerosis; Internal medicine; Antibody; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.03205792600054316,"gpt":0.2312441609377451,"spread":0.1991862349372019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006372645,0.0002688016,0.0004775679,0.00007537263,0.0004497173,0.0000620323,0.0001009698,0.0001434135,0.0001046352],"category_scores_gemma":[0.0002856266,0.0001787205,0.0001270644,0.00007926171,0.0005476137,0.000161956,0.00006985375,0.0001991145,0.000009474014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002627772,"about_ca_system_score_gemma":0.00001786006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006417508,"about_ca_topic_score_gemma":0.0001783655,"domain_scores_codex":[0.9985622,0.00006333367,0.0003624114,0.0004719483,0.0002270812,0.0003130444],"domain_scores_gemma":[0.9990216,0.0001231325,0.0002887211,0.0004045353,0.00004234764,0.0001196587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008797278,0.001505828,0.9857319,0.00004157226,0.0002038559,0.00006331249,0.00008322146,0.0001684127,0.002154349,0.00008259458,0.00001668199,0.009068562],"study_design_scores_gemma":[0.008999025,0.002431716,0.9855064,0.0001581082,0.0003319974,0.0001636765,0.00006423869,0.001524808,0.0001693587,0.0002282759,0.0002188193,0.0002036037],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953101,0.0006117471,0.0002608904,0.00121648,0.0001356325,0.0006606283,0.00002280851,0.00006982095,0.001711944],"genre_scores_gemma":[0.9980428,0.001435972,0.0001713305,0.00004699802,0.000008255211,0.00003851917,0.00009308443,0.00002848732,0.0001346168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008864958,"threshold_uncertainty_score":0.728801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2761661211","doi":"10.1016/j.msard.2017.10.004","title":"Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Depression (economics); Multiple sclerosis; Medicine; Antidepressant; Clinical trial; Disease; Comorbidity; Quality of life (healthcare); Randomized controlled trial; Psychiatry; Internal medicine; Anxiety","retraction":null,"screen_n_in":null,"score":{"opus":0.5195576048701573,"gpt":0.510673184639342,"spread":0.00888442023081537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0100058,0.00100964,0.01194325,0.0006843779,0.0003636062,0.0000651765,0.000394154,0.0009982868,0.00003349855],"category_scores_gemma":[0.06473351,0.0006115919,0.001709691,0.0007220812,0.000930713,0.0003632986,0.0005102073,0.0009230705,0.000005623801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001069291,"about_ca_system_score_gemma":0.0005580939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001350435,"about_ca_topic_score_gemma":0.0008081066,"domain_scores_codex":[0.9844424,0.003271032,0.008886602,0.001769891,0.0009605853,0.0006695107],"domain_scores_gemma":[0.978912,0.01379487,0.004479385,0.001636661,0.0004636202,0.0007134585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0006823979,0.001205045,0.09391695,0.01234644,0.0015092,0.000005565881,0.0002036784,0.000007925015,0.00001752435,0.000001384652,0.0002739668,0.8898299],"study_design_scores_gemma":[0.0236197,0.002427222,0.2128337,0.6560743,0.004633339,0.00001040497,0.0002715578,0.0006354456,0.00001452925,0.00000549453,0.09863536,0.0008388781],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01096403,0.979551,0.00007842859,0.0002487711,0.0002214727,0.008157478,0.0003406579,0.00004969919,0.0003885227],"genre_scores_gemma":[0.02308174,0.9735214,0.00196461,0.0000415047,0.00009183864,0.0008380843,0.0002275803,0.0001292279,0.0001040078],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8889911,"threshold_uncertainty_score":0.9996336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2001146581","doi":"10.1016/j.msard.2013.11.005","title":"Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Tolerability; Adverse effect; Clinical trial; Disease; Interferon; Intensive care medicine; Depression (economics); Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.09804602375119577,"gpt":0.3178976922982854,"spread":0.2198516685470896,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009464404,0.001235303,0.004525538,0.000796252,0.0003427063,0.000120894,0.0003172378,0.001137233,0.0001097791],"category_scores_gemma":[0.0009865075,0.0009536811,0.0005837966,0.0007288171,0.001729099,0.0003140796,0.0009796537,0.001567404,0.0000120836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000255233,"about_ca_system_score_gemma":0.0001178908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005982051,"about_ca_topic_score_gemma":0.001015054,"domain_scores_codex":[0.9935755,0.0005386274,0.002454761,0.001749735,0.000638018,0.001043406],"domain_scores_gemma":[0.9963409,0.001370572,0.0005401791,0.0009437022,0.0001928892,0.0006117279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0002793563,0.0006288898,0.1997254,0.01516149,0.0006494073,0.000003772907,0.0005538284,0.000001666806,0.0003040972,0.000003023958,0.0000385837,0.7826505],"study_design_scores_gemma":[0.008305886,0.0006942645,0.9365869,0.04628756,0.001049821,0.00002656368,0.0003194548,0.0005047406,0.00001907504,0.000006978055,0.005044729,0.00115401],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2462967,0.7489358,0.00001039853,0.0001373835,0.0001665761,0.004061639,0.0001781081,0.00007770999,0.0001357354],"genre_scores_gemma":[0.3551506,0.644098,0.00009617078,0.00001047277,0.00002736675,0.0002711149,0.0001641357,0.0001058583,0.00007624099],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7814965,"threshold_uncertainty_score":0.9992914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2771416990","doi":"10.1016/j.msard.2017.12.006","title":"Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Biogen; National Multiple Sclerosis Society","keywords":"Medicine; Quality of life (healthcare); Multiple sclerosis; Logistic regression; Patient satisfaction; Internal medicine; Disease; Physical therapy; Psychiatry; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.05411997262552112,"gpt":0.2803935104348471,"spread":0.2262735378093259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0002923652,0.000554915,0.0007713572,0.0003457968,0.001325839,0.0002572877,0.0001506244,0.0003836662,0.00009151257],"category_scores_gemma":[0.0007088141,0.0004502333,0.0001498236,0.0001812287,0.0009565494,0.0004585694,0.0002478033,0.0004475357,0.0000312985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002383534,"about_ca_system_score_gemma":0.0000606098,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01009059,"about_ca_topic_score_gemma":0.008415951,"domain_scores_codex":[0.9969693,0.0001284627,0.0005996093,0.001005682,0.0004687274,0.0008282081],"domain_scores_gemma":[0.9980851,0.0003332688,0.0002644573,0.0008201462,0.00007671423,0.0004203187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003907242,0.0003673378,0.7253775,0.00006292971,0.0004260411,0.000006602998,0.001380799,0.000035168,0.02065253,0.00001008171,0.0001081482,0.2511822],"study_design_scores_gemma":[0.0196975,0.0008195777,0.9659762,0.0003335859,0.0001394383,0.00001018806,0.001592792,0.01006989,0.0003889476,0.00003074976,0.000492071,0.0004490783],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913383,0.003254883,0.0000107359,0.002617349,0.0002402393,0.00151582,0.00006606553,0.0001364803,0.0008201994],"genre_scores_gemma":[0.9667444,0.03204639,0.000251706,0.00005823749,0.0000595786,0.0002347928,0.00003171904,0.00008266837,0.0004905355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2507331,"threshold_uncertainty_score":0.9999743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4311086874","doi":"10.1016/j.msard.2022.104459","title":"Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Bayer Vital; EMD Serono; Deutsche Forschungsgemeinschaft; European Commission; Sanofi; Bayer HealthCare; Bristol-Myers Squibb; CSL Behring; Fresenius Medical Care North America; Biogen; Celgene; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Merck KGaA; Pfizer","keywords":"Cladribine; Medicine; Multiple sclerosis; Expert opinion; Term (time); Relapsing remitting; Dermatology; Systematic review; Alternative medicine; MEDLINE; Intensive care medicine; Medical physics; Immunology; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2194334906312244,"gpt":0.3657992478978137,"spread":0.1463657572665893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002301935,0.001182906,0.00552413,0.0007931953,0.0005793006,0.0001036384,0.0007310007,0.0005200608,0.0002027529],"category_scores_gemma":[0.01210612,0.0007052124,0.00198805,0.002256836,0.0005800119,0.000303199,0.0005866104,0.001392677,0.00000636027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003282693,"about_ca_system_score_gemma":0.0002715931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002278002,"about_ca_topic_score_gemma":0.0001066474,"domain_scores_codex":[0.9916763,0.001495534,0.003189291,0.001322325,0.001471134,0.0008453789],"domain_scores_gemma":[0.9832768,0.01174038,0.002257946,0.001914819,0.0005131007,0.0002969135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002704825,0.000665912,0.0005031882,0.8374265,0.001945487,0.000002801171,0.0004502753,0.000006517648,0.000115036,0.00003618616,0.004550023,0.1540276],"study_design_scores_gemma":[0.002021881,0.0006270421,0.002367805,0.9281018,0.001275796,0.000009690977,0.00009866099,0.0002324299,0.00001659126,0.000001780956,0.06464639,0.0006000886],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001067419,0.9813437,0.00001187437,0.0007311114,0.0005166368,0.01651146,0.0006333464,0.0000871836,0.00005796879],"genre_scores_gemma":[0.001162059,0.9917058,0.0001922771,0.0002278274,0.00008143381,0.005365947,0.0007685198,0.0002105537,0.000285614],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1534275,"threshold_uncertainty_score":0.9995399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}